New epigenetic reprogramming factors: functional testing in ES and iPS cells and development of small molecule modulators
New epigenetic reprogramming factors: functional testing in ES and iPS cells and development of small molecule modulators
批准号:
BB/H008071/1
负责人:
Wolf Reik
金额:
$57.71万
依托单位:
依托单位国家:
英国
项目类别:
Research Grant
财政年份:
2010
资助国家:
英国
项目状态:
已结题
起止时间:
2010 至 --
中文摘要
点击翻译按钮获取中文摘要
英文摘要
Stem cells and regenerative medicine hold great promise for human health and healthy ageing in the future. A number of exciting technologies have recently been developed by which the derivation of embryonic stem cells from adult cell types is now possible, albeit inefficiently. This includes the transfer of reprogramming factors into adult cells, resulting in the generation of induced pluripotent stem cells (iPS cells). This technology, however, is inefficient and a particular bottleneck appears to be the reprogramming of the epigenome. Epigenetics or the epigenome refers to all the modifications to DNA and the chromatin that are important for the function of the genome in the context of development and in the adult organism in different organs and tissues. Importantly, in germ cells and early embryos, the epigenome is reprogrammed on a genome-wide scale, so that development of a new organism and of new stem cells is possible. Work in our laboratory and that of others has revealed several features of this genome-wide epigenetic reprogramming. In collaboration with the company CellCentric, we have begun to set up a number of systematic screens for the isolation of epigenetic reprogramming factors, including those that can erase DNA methylation from the genome. The current programme of work, again with CellCentric, aims to assess the function of these new reprogramming factors in germ cells and early embryos, embryonic stem cells, and in the generation of iPS cells. CellCentric will, in particular, work on the isolation of small molecules that can alter the function of our reprogramming factors, which will then be tested in embryonic stem cells and iPS cells. The combined programme of work will shed new light on the fundamental process of epigenetic reprogramming, and provide new tools for the manipulation of stem cells and the translation into approaches to regenerative medicine and healthy ageing.
期刊论文(7)
专著(0)
科研奖励(0)
会议论文
DOI:
10.1038/nature11925
发表时间:
2013-03-21
期刊:
Nature
影响因子:
64.8
作者:
[]
通讯作者:
A screen for hydroxymethylcytosine and formylcytosine binding proteins suggests functions in transcription and chromatin regulation.
羟甲基胞嘧啶和甲酰胞嘧啶结合蛋白的筛选表明其在转录和染色质调节中的功能。
DOI:
10.1186/gb-2013-14-10-r119
发表时间:
2013
期刊:
Genome biology
影响因子:
12.3
作者:
[Iurlaro M, Ficz G, Oxley D, Raiber EA, Bachman M, Booth MJ, Andrews S, Balasubramanian S, Reik W]
通讯作者:
Reik W
DOI:
10.1016/j.celrep.2014.11.034
发表时间:
2014-12-24
期刊:
Cell reports
影响因子:
8.8
作者:
[Peat JR, Dean W, Clark SJ, Krueger F, Smallwood SA, Ficz G, Kim JK, Marioni JC, Hore TA, Reik W]
通讯作者:
Reik W
Expanding the potency of stem cells with epigenetic modifiers
-
批准号:BB/M013065/1
-
项目类别:Research Grant
-
资助金额:$1.01万
-
财政年份:2014
-
负责人:Wolf Reik
-
依托单位:
Next Generation Sequencing High Throughput Epigenomics
-
批准号:G0801156/1
-
项目类别:Research Grant
-
资助金额:$99.09万
-
财政年份:2009
-
负责人:Wolf Reik
-
依托单位:
An in vitro compartmentalisation screen for mammalian DNA demethylases
-
批准号:G0801727/1
-
项目类别:Research Grant
-
资助金额:$46.61万
-
财政年份:2009
-
负责人:Wolf Reik
-
依托单位:
DTG 2008
-
批准号:G0800095-1/1
-
项目类别:Training Grant
-
资助金额:$15.6万
-
财政年份:2008
-
负责人:Wolf Reik
-
依托单位:
Role of cytidine deaminases in epigenetic reprogramming and demethylation of DNA
-
批准号:G0700098/1
-
项目类别:Research Grant
-
资助金额:$120.17万
-
财政年份:2008
-
负责人:Wolf Reik
-
依托单位:
Mechanisms of epigenetic gene silencing caused by the long non-coding Kcnq1ot1 RNA - a key regulator of BWS
-
批准号:G0700760/1
-
项目类别:Research Grant
-
资助金额:$83.84万
-
财政年份:2008
-
负责人:Wolf Reik
-
依托单位:
国内基金
海外基金
登录
查看更多内容
NPM1表观重塑巨噬细胞代谢及修复表型在心肌缺血损伤中的调控作用
-
批准号:82371825
-
项目类别:面上项目
-
资助金额:49.00万元
-
批准年份:2023
-
负责人:占贞贞
-
依托单位:
GLS1通过α-KG调控表观遗传修饰在实验性近视巩膜重塑中的作用机制
-
批准号:82371092
-
项目类别:面上项目
-
资助金额:49.00万元
-
批准年份:2023
-
负责人:柯碧莲
-
依托单位:
小鼠肺腺鳞癌转分化类器官模型的建立及表观调控分子机制研究
-
批准号:32100593
-
项目类别:青年科学基金项目(C类)
-
资助金额:30.0万元
-
批准年份:2021
-
负责人:童欣媛
-
依托单位:
MCM2、POLE3调控亲代组蛋白传递的分子机制和生物学功能
-
批准号:32070610
-
项目类别:面上项目
-
资助金额:58.0万元
-
批准年份:2020
-
负责人:甘海云
-
依托单位:
转录因子剂量效应调控体细胞重编程的表观遗传机制研究
-
批准号:31970681
-
项目类别:面上项目
-
资助金额:58.0万元
-
批准年份:2019
-
负责人:刘晶
-
依托单位:
组蛋白分子伴侣FACT调控异染色质转录沉默的作用机制研究
-
批准号:31900433
-
项目类别:青年科学基金项目
-
资助金额:25.0万元
-
批准年份:2019
-
负责人:杨佳怡
-
依托单位:
探索VASH2转录激活对肝细胞癌血管生成和上皮间质转化的作用及机制
-
批准号:81172267
-
项目类别:面上项目
-
资助金额:58.0万元
-
批准年份:2011
-
负责人:高文涛
-
依托单位:
肿瘤DNA低甲基化发生分子机理及其对白血病发病重要性的研究
-
批准号:30872933
-
项目类别:面上项目
-
资助金额:36.0万元
-
批准年份:2008
-
负责人:张权庚
-
依托单位:
高等植物远缘杂交诱导的表观遗传变异(epigenetic variation)现象及其在物种进化和新种形成中的作用
-
批准号:30430060
-
项目类别:重点项目
-
资助金额:140.0万元
-
批准年份:2004
-
负责人:刘宝
-
依托单位: